Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $74.60 in the prior trading day, Bio-Techne Corp (NASDAQ: TECH) closed at $71.83, down -3.71%. In other words, the price has decreased by -$3.71 from its previous closing price. On the day, 1.37 million shares were traded. TECH stock price reached its highest trading level at $74.0 during the session, while it also had its lowest trading level at $71.12.
Ratios:
Our goal is to gain a better understanding of TECH by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 60.86 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 46.58. For the most recent quarter (mrq), Quick Ratio is recorded 3.26 and its Current Ratio is at 4.56. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.18.
On February 08, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $80.
Stifel Downgraded its Buy to Hold on February 02, 2024, while the target price for the stock was maintained at $65.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 27 ’25 when Kelderman Kim sold 13,392 shares for $77.29 per share. The transaction valued at 1,035,013 led to the insider holds 39,004 shares of the business.
KIM KELDERMAN bought 13,392 shares of TECH for $1,031,854 on Jan 27 ’25. On Aug 08 ’24, another insider, BAUMGARTNER ROBERT V, who serves as the Director of the company, sold 16,000 shares for $72.10 each. As a result, the insider received 1,153,664 and left with 43,401 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TECH now has a Market Capitalization of 11413212160 and an Enterprise Value of 11624576000. As of this moment, Bio-Techne’s Price-to-Earnings (P/E) ratio for their current fiscal year is 76.55, and their Forward P/E ratio for the next fiscal year is 32.95. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.38. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.74 while its Price-to-Book (P/B) ratio in mrq is 5.34. Its current Enterprise Value per Revenue stands at 9.922 whereas that against EBITDA is 37.679.
Stock Price History:
The Beta on a monthly basis for TECH is 1.26, which has changed by 0.04800117 over the last 52 weeks, in comparison to a change of 0.23095727 over the same period for the S&P500. Over the past 52 weeks, TECH has reached a high of $85.57, while it has fallen to a 52-week low of $61.16. The 50-Day Moving Average of the stock is -3.00%, while the 200-Day Moving Average is calculated to be -3.47%.
Shares Statistics:
The stock has traded on average 938.34K shares per day over the past 3-months and 1064700 shares per day over the last 10 days, according to various share statistics. A total of 158.88M shares are outstanding, with a floating share count of 157.11M. Insiders hold about 1.12% of the company’s shares, while institutions hold 99.02% stake in the company. Shares short for TECH as of 1736899200 were 4051390 with a Short Ratio of 4.32, compared to 1734048000 on 3509200. Therefore, it implies a Short% of Shares Outstanding of 4051390 and a Short% of Float of 2.92.
Dividends & Splits
In the trailing 12 months, TECH’s forward annual dividend rate was 0.32, compared to 0.32 this year. Against a Trailing Annual Dividend Yield of 0.004289544The stock’s 5-year Average Dividend Yield is 0.41. The current Payout Ratio is 30.61% for TECH, which recently paid a dividend on 2024-11-08 with an ex-dividend date of 1731024000. Stock splits for the company last occurred on 2022-11-30 when the company split stock in a 4:1 ratio.